Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Windtree Therapeutics Inc (NASDAQ:WINT)

During the Trading Day
2.42 -0.82 / -25.31%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.36 -0.06 / -2.48%
Volume: 2.1K
Health Technology

Company Description

Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Its products include SURFAXIN and AFECTAIR. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Contact Information

Windtree Therapeutics, Inc.
2600 Kelly Road
Warrington Pennsylvania 18976-3622
P:(215) 488-9300
Investor Relations:



Mutual fund holders5.31%
Other institutional35.82%
Individual stakeholders0.72%

Top Executives

Craig E. FraserPresident, Chief Executive Officer & Director
John Andrew TattoryChief Financial Officer, Treasurer & Senior VP
Mary B. TempletonSecretary, Senior Vice President & General Counsel
Steven G. SimonsonChief Development Officer & Senior Vice President
Kathryn A. ColeSenior Vice President-Human Resources